Selexis 
Selexis SA 公司是一家总部位于瑞士日内瓦的全球性生命科学公司。公司主要从事生命科学领域创新技术的研究工作；同时为新药研发、细胞株开发、治疗性蛋白的大规模产业化生产提供世界一流的专家服务工作。公司独有的SUREtechnology平台是一种新型基于DNA-based元素技术的蛋白表平台，该新型技术能够控制所有扑入动物细胞中染色质的动态组装过程，从而促使哺乳动物细胞能够稳定、高表达重组蛋白。从新药的创新研发到后期临床试验，Selexis SA公司研究开发的细胞株已经被广泛运用于生命科学研究领域。

Headquartered in Geneva, Switzerland, Selexis SA is a global life science company with innovative technologies and world-class expert services for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins. The Company’s SUREtechnology Platform™ is based on Selexis Genetic Elements™ — novel DNA-based elements that control the dynamic organization of chromatin within all mammalian cells and allow for higher and more stable expression of recombinant proteins. Selexis has generated cell lines being used in a variety of programs from drug discovery to late-stage clinical trials.